Aastrom Biosciences Inc (ASTM.OQ)

ASTM.OQ on NASDAQ Stock Exchange Capital Market

0.45USD
1 Aug 2013
Price Change (% chg)

$0.05 (+11.87%)
Prev Close
$0.40
Open
$0.42
Day's High
$0.45
Day's Low
$0.40
Volume
99,538
Avg. Vol
53,346
52-wk High
$1.99
52-wk Low
$0.34

ASTM.OQ

Chart for ASTM.OQ

About

Aastrom Biosciences, Inc. (Aastrom) is a development-stage company. The Company is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. The Company is developing patient-specific, expanded multicellular therapies for use in the treatment of severe,... (more)

Overall

Beta: 0.06
Market Cap (Mil.): $18.63
Shares Outstanding (Mil.): 45.66
Dividend: --
Yield (%): --

Financials

  ASTM.OQ Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -0.72 -- --
ROI: -225.99 19.48 18.76
ROE: -- 20.17 19.59
Search Stocks

Aastrom Biosciences ends drug trial, to cut half its workforce

- Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia (CLI), a form of peripheral arterial disease, and cut about half of its workforce, driving its shares to an all-time low.

27 Mar 2013

Aastrom Biosciences ends drug trial, to cut half its workforce

March 27 - Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia - a form of peripheral arterial disease - and cut about half of its workforce.

27 Mar 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$472.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks